DSGN - Design Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DSGN is currently covered by 2 analysts with an average price target of $17.24. This is a potential upside of $4.75 (38.03%) from yesterday's end of day stock price of $12.49.

Design Therapeutics's activity chart (see below) currently has 25 price targets and 29 ratings on display. The stock rating distribution of DSGN is 80% HOLD and 20% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 82.33 days.

Highest price target for DSGN is $14, Lowest price target is $14, average price target is $14.

Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 03-Dec-2025. First documented stock forecast 20-Apr-2021.

Best performing analysts who are covering DSGN - Design Therapeutics:

Laura Chico Yasmeen Rahimi Joseph Schwartz

Currently out of the existing stock ratings of DSGN, 4 are a HOLD (80%), 1 are a BUY (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Dec-2025

$14

$2.77 (24.67%)

4 months 7 days ago
(03-Dec-2025)

0/3 (0%)

$4.23 (43.30%)

Hold Since 07-May-2024

$12

$0.77 (6.86%)

$42

1 years 11 months 3 days ago
(07-May-2024)

0/4 (0%)

$7.31 (155.86%)

Hold Since 14-Nov-2023

$5

$-6.23 (-55.48%)

$6

2 years 4 months 27 days ago
(14-Nov-2023)

3/6 (50%)

$2.71 (118.34%)

247

Show more analysts

Please expand the browser size to see the chart

What is DSGN (Design Therapeutics) average time for price targets to be met?

On average it took 82.33 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on DSGN (Design Therapeutics) with a proven track record?

LAURA CHICO

Which analyst has the current lower performing score on DSGN (Design Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on DSGN (Design Therapeutics)?

Laura Chico works at WEDBUSH and has 30 price targets and 23 ratings on DSGN

Which analyst is the currently most bullish on DSGN (Design Therapeutics)?

Joseph Schwartz with highest potential upside - $2.77

Which analyst is the currently most reserved on DSGN (Design Therapeutics)?

Laura Chico with lowest potential downside - -$6.23

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?